BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16180919)

  • 1. Prediction of T-cell epitopes using biosupport vector machines.
    Yang ZR; Johnson FC
    J Chem Inf Model; 2005; 45(5):1424-8. PubMed ID: 16180919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of T-cell epitopes based on least squares support vector machines and amino acid properties.
    Li S; Yao X; Liu H; Li J; Fan B
    Anal Chim Acta; 2007 Feb; 584(1):37-42. PubMed ID: 17386582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd.
    Aoshi T; Suzuki M; Uchijima M; Nagata T; Koide Y
    J Immunol Methods; 2005 Mar; 298(1-2):21-34. PubMed ID: 15847794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic approach for comprehensive T-cell epitope discovery using peptide libraries.
    Beissbarth T; Tye-Din JA; Smyth GK; Speed TP; Anderson RP
    Bioinformatics; 2005 Jun; 21 Suppl 1():i29-37. PubMed ID: 15961469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design.
    Halling-Brown M; Shaban R; Frampton D; Sansom CE; Davies M; Flower D; Duffield M; Titball RW; Brusic V; Moss DS
    Mol Immunol; 2009 Aug; 46(13):2699-705. PubMed ID: 19560824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of human T-cell epitopes of allergens.
    Zeiler T; Virtanen T
    Methods Mol Med; 2008; 138():51-6. PubMed ID: 18615243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods and protocols for prediction of immunogenic epitopes.
    Tong JC; Tan TW; Ranganathan S
    Brief Bioinform; 2007 Mar; 8(2):96-108. PubMed ID: 17077136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are bacterial vaccine antigens T-cell epitope depleted?
    Halling-Brown M; Sansom CE; Davies M; Titball RW; Moss DS
    Trends Immunol; 2008 Aug; 29(8):374-9. PubMed ID: 18603471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct mapping of MHC class II epitopes.
    Milosevic S; Behrends U; Christoph H; Mautner J
    J Immunol Methods; 2005 Nov; 306(1-2):28-39. PubMed ID: 16168435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties.
    Tung CW; Ho SY
    Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE.
    Bian H; Hammer J
    Methods; 2004 Dec; 34(4):468-75. PubMed ID: 15542373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The validity of predicted T-cell epitopes.
    Lundegaard C; Nielsen M; Lund O
    Trends Biotechnol; 2006 Dec; 24(12):537-8. PubMed ID: 17045685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational prediction and identification of HLA-A2.1-specific Ebola virus CTL epitopes.
    Sundar K; Boesen A; Coico R
    Virology; 2007 Apr; 360(2):257-63. PubMed ID: 17123567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and validation of T-cell epitopes using the IFN-gamma ELISPOT assay.
    Wulf M; Hoehn P; Trinder P
    Methods Mol Biol; 2009; 524():439-46. PubMed ID: 19377964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting class I major histocompatibility complex (MHC) binders using multivariate statistics: comparison of discriminant analysis and multiple linear regression.
    Doytchinova IA; Flower DR
    J Chem Inf Model; 2007; 47(1):234-8. PubMed ID: 17238269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
    Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M
    J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.
    Kobayashi H; Nagato T; Takahara M; Sato K; Kimura S; Aoki N; Azumi M; Tateno M; Harabuchi Y; Celis E
    Cancer Res; 2008 Feb; 68(3):901-8. PubMed ID: 18245493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
    Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
    J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus.
    Moutaftsi M; Peters B; Pasquetto V; Tscharke DC; Sidney J; Bui HH; Grey H; Sette A
    Nat Biotechnol; 2006 Jul; 24(7):817-9. PubMed ID: 16767078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.